$22.05
▼ -2.0% Today
as of Sep 4, 16:54 ET
Last 30 days
Recent Press Releases & News
Why Is Sarepta Therapeutics (SRPT) Up 37% Since Last Earnings Report?
Sarepta Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
SRPT On Track For Best Week In 5 Months Ahead Of Late-2026 Clinical Data — Retail Eyes ‘Monumental Comeback’
Overview
52-week range
$15
$25
69% of range
Avg surprise (last 3)
+156.3%
Avg reaction (last 2)
-10.4%
50% positive
Latest IV / EM
96%
EM ±4.0% · $23 · Sep 4
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.05 | — | — | — | — | financials |
| Wed May 6, 2026 | Mar/2026 | $3.09 | $0.39 | +692.3% | +180.5% | +5.7% | earnings |
| Wed Aug 6, 2025 | Jun/2025 | $1.70 | $0.78 | +118.0% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $-3.84 | $-0.87 | -341.4% | — | -26.6% | earnings |
| Sat Sep 30, 2023 | Sep 2023 | $-0.46 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.27 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-5.86 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $401M | $731M | — | — | $611M | $745M | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $13M | $358M | — | $-103M | $116M | $-300M | — | $22M |
| Net income | $-5M | $331M | — | — | $197M | $-448M | — | — |
| EPS (diluted) | $-0.05 | $2.88 | — | — | $1.89 | $-4.60 | — | — |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $571M | $464M | $801M | $613M | $511M | $241M | $1.10B | $198M |
| Inventory | $904M | $1.00B | $915M | $1.08B | $994M | $941M | $750M | $566M |
| Total current assets | $2.22B | $2.31B | $2.54B | $2.72B | $2.66B | $2.43B | $3.07B | $2.69B |
| Total assets | $3.19B | $3.18B | $3.35B | $3.49B | $3.68B | $3.47B | $3.96B | $3.60B |
| Long-term debt | $848M | $838M | $829M | — | — | — | — | $1.23B |
| Total liabilities | $1.66B | $1.67B | $2.21B | $2.17B | $2.32B | $2.32B | $2.44B | $2.38B |
| Total equity | $1.53B | $1.51B | $1.14B | $1.32B | $1.40B | $1.19B | $1.53B | $1.22B |